XML 229 R66.htm IDEA: XBRL DOCUMENT v3.22.1

Investments (Narrative) (Details)								1 Months Ended							12 Months Ended
	Feb. 05, 2020 USD ($) shares	Feb. 04, 2020 USD ($)	Nov. 04, 2019 $ / shares	Nov. 04, 2019 USD ($)	May 07, 2019 USD ($) $ / shares	May 07, 2019 USD ($) shares	Sep. 06, 2018 USD ($)	Feb. 17, 2021 $ / shares	Feb. 04, 2020 USD ($) shares	Sep. 20, 2019 USD ($) shares	Apr. 24, 2019 $ / shares	Apr. 24, 2019 USD ($) shares	Apr. 16, 2019 $ / shares	Apr. 16, 2019 USD ($) shares	Dec. 31, 2021 CAD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2019 CAD ($) $ / shares	Dec. 31, 2021 USD ($) shares	Feb. 04, 2021 USD ($)	Dec. 31, 2020 CAD ($) $ / shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Oct. 31, 2018 $ / shares	May 31, 2018 $ / shares
Disclosure Of Investments [Line Items]
Proceeds from sale																$ 0	$ 6,477,510	$ 462,303
Fair value of the shares																				$ 818,262			$ 1,676,745	$ 8,862,744
Proceeds from issuing shares																$ 38,341,407	25,100,459	$ 3,431,294
Class B share capital
Disclosure Of Investments [Line Items]
Number of shares issued | shares																				112,794
Share issue price per share | $ / shares			$ 20.10					$ 2.65
Proceeds from issuing shares				$ 3,455,898
Fair value of shares																				$ 174,537
Pharmadrug Inc.
Disclosure Of Investments [Line Items]
Number of investment shares sold | shares															13,562,387	13,562,387
Proceeds from sale															$ 250	$ 197	652,081
Pharmadrug Inc. | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	652,081
Fair value of the shares																							0	255,075
Pharmadrug Inc. | Share Exchange Agreement
Disclosure Of Investments [Line Items]
Number of shares acquired | shares												13,562,386		13,562,387
Share price per share | $ / shares											$ 0.2212		$ 0.2212
Pharmadrug Inc. | Share Exchange Agreement | Class B share capital
Disclosure Of Investments [Line Items]
Number of shares issued in share exchange | shares										61,892		65,577		65,577
Share issue price per share | $ / shares											$ 45.75		$ 45.75
Value of shares issued in share exchange												$ 2,256,900		$ 2,256,900
Loss on change in fair value of derivative liability										$ 1,069,798
Cannara Biotech Inc. | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	5,825,429
Fair value of the shares																							0	6,822,637
Cannara Biotech Inc. | Class B share capital
Disclosure Of Investments [Line Items]
Number of investment shares sold | shares	85,003,750
Proceeds from sale	$ 5,825,429
Gain (loss) on sale of investment	$ (997,208)
True Pharma Strip Inc.
Disclosure Of Investments [Line Items]
Value of subscribed equity units in brokered private placement							$ 1,128,450
True Pharma Strip Inc. | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	0
Fair value of the shares																				197			0	0
HUGE Shops
Disclosure Of Investments [Line Items]
Proceeds from sale															$ 200,000	$ 157,760
Number of shares held | shares															17,333,333	17,333,333
Subscription price per share | $ / shares																			$ 0.075
HUGE Shops | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	0
Fair value of the shares																				157,760			600,433	572,401
SciCann Therapeutics Inc.
Disclosure Of Investments [Line Items]
Proceeds from sale															$ 100	$ 79
Number of shares held | shares															117,648	117,648
Subscription price per share | $ / shares																									$ 17	$ 17
SciCann Therapeutics Inc. | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	$ 0
Fair value of the shares																				79			195,679	535,824
Solarvest BioEnergy Inc.
Disclosure Of Investments [Line Items]
Share price per share | $ / shares																						$ 0.19
Share issue price per share | $ / shares															$ 0.155
Number of shares held | shares						3,000,000
Number of warrants held | shares						3,000,000
Principal amount of convertible debenture					$ 1,805,520	$ 1,805,520
Fair value of shares and warrants acquired					2,256,900	2,256,900
Exercise price of warrants | $ / shares																						0.25
Quoted market price of investments | $ / shares															$ 0.155							$ 0.19
Risk free rate of warrants																	0.20%
Expected volatility of warrants																	112.00%
Expected term of warrants																	4 months 6 days
Expected dividend yield																	0.00%
Solarvest BioEnergy Inc. | Shares
Disclosure Of Investments [Line Items]
Proceeds from sale																	$ 0
Fair value of the shares																				$ 366,792			$ 447,678	$ 327,251
Solarvest BioEnergy Inc. | Share Exchange Agreement
Disclosure Of Investments [Line Items]
Derivative financial liabilities					376,150	376,150
Guaranteed minimum liquidation value of shares					$ 2,256,900	$ 2,256,900																$ 2,256,900
Solarvest BioEnergy Inc. | Share Exchange Agreement | Class B share capital
Disclosure Of Investments [Line Items]
Number of shares issued in share exchange | shares						49,751			225,371
Share issue price per share | $ / shares					$ 50.25
Value of shares issued in share exchange						$ 1,880,750
Derivative liability																					$ 1,990,788
Solarvest BioEnergy Inc. | Share exchange agreement
Disclosure Of Investments [Line Items]
Value of shares issued in share exchange		$ 1,356,373
Loss on change in fair value of derivative liability																			$ 225,371
Gain on settlement of derivative liability		634,415							$ 634,415
Derivative liability		$ 1,990,788							$ 1,990,788

X

- References

No definition available.

+ Details

Name:	huge_DisclosureOfInvestmentsLineItems
Namespace Prefix:	huge_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the price per share of excercise price of warrants.

+ References

No definition available.

+ Details

Name:	huge_ExercisePriceOfWarrants
Namespace Prefix:	huge_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Expected dividend yield of warrants.

+ References

No definition available.

+ Details

Name:	huge_ExpectedDividendYieldOfWarrants
Namespace Prefix:	huge_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the expected term of warrants.

+ References

No definition available.

+ Details

Name:	huge_ExpectedTermOfWarrants
Namespace Prefix:	huge_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents expected volatility of warrants.

+ References

No definition available.

+ Details

Name:	huge_ExpectedVolatilityOfWarrants
Namespace Prefix:	huge_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount related to fair value of shares.

+ References

No definition available.

+ Details

Name:	huge_FairValueOfShares
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the fair value of shares and warrants acquired.

+ References

No definition available.

+ Details

Name:	huge_FairValueOfSharesAndWarrantsAcquired
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Gain on settlement of derivative liability.

+ References

No definition available.

+ Details

Name:	huge_GainOnSettlementOfDerivativeLiability
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents guaranteed minimum liquidation value of shares.

+ References

No definition available.

+ Details

Name:	huge_GuaranteedMinimumLiquidationValueOfShares
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the number of investment shares sold

+ References

No definition available.

+ Details

Name:	huge_NumberOfInvestmentSharesSold
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of shares acquired.

+ References

No definition available.

+ Details

Name:	huge_NumberOfSharesAcquired
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the number of shares held.

+ References

No definition available.

+ Details

Name:	huge_NumberOfSharesHeld
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the number of shares issued in share exchange.

+ References

No definition available.

+ Details

Name:	huge_NumberOfSharesIssuedInShareExchange
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the number of warrants held.

+ References

No definition available.

+ Details

Name:	huge_NumberOfWarrantsHeld
Namespace Prefix:	huge_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount related to principal amount of borrowings.

+ References

No definition available.

+ Details

Name:	huge_PrincipalAmountOfBorrowings
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents the price per share related to quoted market price of investment.

+ References

No definition available.

+ Details

Name:	huge_QuotedMarketPriceOfInvestments
Namespace Prefix:	huge_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Represents the risk free rate of warrants.

+ References

No definition available.

+ Details

Name:	huge_RiskFreeRateOfWarrants
Namespace Prefix:	huge_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the price per share of shares issued.

+ References

No definition available.

+ Details

Name:	huge_ShareIssuePricePerShare
Namespace Prefix:	huge_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents Share price per share.

+ References

No definition available.

+ Details

Name:	huge_SharePrices
Namespace Prefix:	huge_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Represents the subscription price per share.

+ References

No definition available.

+ Details

Name:	huge_SubscriptionPricePerShare
Namespace Prefix:	huge_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Represents the amount related to shares issued in share exchange.

+ References

No definition available.

+ Details

Name:	huge_ValueOfSharesIssuedInShareExchange
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents the value of subscribed equity units in brokered private placement.

+ References

No definition available.

+ Details

Name:	huge_ValueOfSubscribedEquityUnitsInBrokeredPrivatePlacement
Namespace Prefix:	huge_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 55
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_CurrentDerivativeFinancialLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 55
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DerivativeFinancialLiabilities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The gains (losses) on disposals of investments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 98
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_GainsLossesOnDisposalsOfInvestments
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 55
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 85
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_LossesOnChangeInFairValueOfDerivatives
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The number of shares issued by the entity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 106
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_NumberOfSharesIssued
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The cash inflow from issuing shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2021-01-01
-Paragraph 17
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_ProceedsFromIssuingShares
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2021-01-01
-Paragraph 16
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	ifrs-full_ClassesOfShareCapitalAxis=huge_ClassBCommonStockSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_PharmadrugIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_TypeOfArrangementsAxis=huge_SecuritiesExchangeAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_CannaraBiotechIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_TruePharmaStripIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_HugeShopsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_ScicannTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_OtherInvestmentsNameOfEntityAxis=huge_SolarvestBioEnergyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	huge_TypeOfArrangementsAxis=huge_ShareExchangeAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: